Skip to content
Recall Observatory FDA recall evidence

Drug product

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054

D-310-2013

March 18, 2013

Class III

Product summary

Firm
Reckitt Benckiser Inc
Event
Event 64652
Status
Terminated
Classification
Class III
Quantity
27,718 cases 16 count and 7,551 cases 576 count
Official record key
drug-enforcement:D-310-2013

Official wording

Reason: Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Code information: 16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent